Concepedia

Aimée M. Deaton

AM

Statistics

Publications

27

Citations

4.3K

H-Index

23

Active since

2006

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Harvard University

Massachusetts General Hospital

Amgen (United States)

University of Edinburgh

Aimée M. Deaton is an author at Alnylam Pharmaceuticals (United States) specializing in genetics, life sciences, and medical genetics.

ORCID

Publications per year

2006–2023

27

Publications

27

Plasma proteomic associations with genetics and health in the UK Biobank

Benjamin B. Sun, Joshua Chiou, Matthew Traylor et al. · Nature · 2023 · 1.5K citations · Full text

, , +16

CpG islands influence chromatin structure via the CpG-binding protein Cfp1

John P. Thomson, Peter J. Skene, Jim Selfridge et al. · Nature · 2010 · 645 citations · Full text

, , +14

A Transient Heterochromatic State in Xist Preempts X Inactivation Choice without RNA Stabilization

Bryan K. Sun, Aimée M. Deaton, Jeannie T. Lee · Molecular Cell · 2006 · 291 citations · Full text

, , +11

Cell type–specific DNA methylation at intragenic CpG islands in the immune system

Aimée M. Deaton, Shaun Webb, Alastair Kerr et al. · Genome Research · 2011 · 290 citations · Full text

, , +15

MNase titration reveals differences between nucleosome occupancy and chromatin accessibility

Jakub Mieczkowski, April Cook, Sarah Bowman et al. · Nature Communications · 2016 · 257 citations · Full text

, , +16

1–5 of 27